Key studies that have changed the history and treatment of early HER2+ breast cancer: focus on individual therapy
HER2-positive breast cancer is a unique subtype of the disease, not only in terms of aggressive biology, but also in terms of treatment options. Over the past 15 years, the strategy for treating early HER2-positive breast cancer has undergone a real evolution - from the absence of anti-HER2 therapy...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book |
| Published: |
ABV-press,
2021-01-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|